| Stage | Definition |
|---|---|
| Acquisition | Target: founders, managing partners, and ops leads at B2B agencies, law firms, clinics, and consultancies with $500K–$10M ARR in US, Canada, UAE, Australia, UK |
| Activation | First approved diagnostic produced — Groq brief to Claude output to dashboard Paste Report to Approve — completed end-to-end |
| Retention | Weekly diagnostic cycle maintained — W0 sourcing daily, minimum five diagnostics approved per week, pipeline always moving |
| Revenue | System positioned at $10,000 setup plus $2,500/month retainer. One closed deal at $5,000 average ANR engagement value recovers setup cost in Month 1 |
| Referral | A prospect who receives a diagnostic specific enough to make them think “how did they notice that” has an immediate story — one that does ANR’s marketing for them |
| Metric | Target |
|---|---|
| Groq JSON reliability | > 99% valid structured output per enrichment pass |
| Claude diagnostic specificity | Every finding must be untrue for > 80% of companies in the same industry |
| Contact verification accuracy | Zero outreach sent to wrong or deceased contacts |
| Geography filter precision | Zero non-target country prospects reaching W1 intake |
| Email waterfall coverage | Email found for > 60% of sourced prospects across six APIs |
| Report click tracking | 100% of clicks captured via Cloudflare Worker |
| Metric | Target |
|---|---|
| Prospects sourced per week | 25–35 |
| Diagnostics approved per week | 5–10 |
| Reports sent per week | 5–10 |
| Response rate | Benchmark after first 50 sends |
| Meeting booked rate | Benchmark after first 50 sends |
Diagnostic Quality × Response Rate
The system succeeds when the specificity of each diagnostic is high enough that the response rate significantly exceeds the B2B cold outreach industry average of one to three percent. Both must be measured simultaneously. High diagnostic quality with zero sends is a research project. High send volume with low quality is spam.